Accessibility links
Pfizer Asked to Pull Arthritis Drug Bextra The Food and Drug Administration has asked Pfizer to remove the anti-inflammatory drug Bextra from pharmacy shelves. The painkiller is the latest inhibitor of the enzyme known as cox-2 that has been shown to increase risks to heart, stomach and skin. The FDA named 18 other prescription and over-the-counter medicines that may pose a danger.
thumbnail
Special Series

Safety Concerns Hang over Popular Painkillers

Follow NPR coverage of the links between popular painkillers and heart risks.

Pfizer Asked to Pull Arthritis Drug Bextra

Heard on Morning Edition

Pfizer Asked to Pull Arthritis Drug Bextra

Listen
  • Download
  • <iframe src="https://www.npr.org/player/embed/4582245/4582246" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

The Food and Drug Administration has asked Pfizer to remove the anti-inflammatory drug Bextra from pharmacy shelves. The painkiller is the latest inhibitor of the enzyme known as cox-2 that has been shown to increase risks to heart, stomach and skin. The FDA named 18 other prescription and over-the-counter medicines that may pose a danger.